Genenta Science SPAGNTA -5.26%31 EV-to-FCF is -1.59 as of Jul. 08, 2026. GuruFocus rates GNTA with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 327 Biotechnology companies, Genenta Science SPA ranks worse than 305810.09% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genenta Science SPA's Enterprise Value is $12.64 Mil.
Genenta Science SPA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-7.95 Mil. Therefore, Genenta Science SPA's EV-to-FCF for today is -1.59.
The historical rank and industry rank for Genenta Science SPA's EV-to-FCF or its related term are showing as below:
GNTA'
s EV-to-FCF Range Over the Past 10 Years
Min: -1.88 Med: 0 Max: 0
Current: -1.59
GNTA's EV-to-FCF is ranked worse than 100% of 327
companies
in the Biotechnology industry
Industry Median: 16.69
vs GNTA: -1.59
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genenta Science SPA's PE Ratio (TTM) for today is calculated as:
Genenta Science SPA's share price for today is $1.53.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genenta Science SPA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.387.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genenta Science SPA EV-to-FCF Related Terms
Genenta Science SPA EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Genenta Science SPA's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Genenta Science SPA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genenta Science SPA EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genenta Science SPA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genenta Science SPA's EV-to-FCF falls into.
Genenta Science SPA's current Enterprise Value is $12.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genenta Science SPA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-7.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genenta Science SPA (GNTA) has a EV-to-FCF of -1.59 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genenta Science SPA and its competitors. According to the industry distribution chart, Genenta Science SPA ranks #999999 out of 327 companies in the Biotechnology industry.
Is Genenta Science SPA's EV-to-FCF too high?
Genenta Science SPA's current EV-to-FCF is -1.59. Based on the distribution chart, Genenta Science SPA ranks #999999 out of 327 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Genenta Science SPA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genenta Science SPA ranks #999999 out of 327 companies for EV-to-FCF. This places Genenta Science SPA in the lower half of its industry. The industry median EV-to-FCF is 16.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.69, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genenta Science SPA and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genenta Science SPA's current EV-to-FCF is -1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (GNTA) has a current EV-to-FCF of -1.59. The current EV-to-FCF is -1.59. Genenta Science SPA's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Genenta Science SPA (GNTA), the current EV-to-FCF is -1.59 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
31GF Score
Get the complete analysis for GNTA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNTA has been successfully added to your 
